↓ Skip to main content

Dove Medical Press

Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted

Overview of attention for article published in Drug Design, Development and Therapy, March 2012
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
23 Mendeley
Title
Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
Published in
Drug Design, Development and Therapy, March 2012
DOI 10.2147/dddt.s29916
Pubmed ID
Authors

Olivier Lambert, Dirk Bandilla, Rupa Iyer, Leonore Witchey-Lakshmanan, Nagesh Palepu

Abstract

Epoprostenol, used for the treatment of pulmonary arterial hypertension (PAH), has a number of limitations related to its short half-life in aqueous solution. The aim of this study was to evaluate the stability and microbiological properties of a new formulation, namely epoprostenol sodium with arginine and mannitol excipients (epoprostenol AM; Veletri®; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 26%
Researcher 4 17%
Student > Ph. D. Student 3 13%
Student > Bachelor 2 9%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 6 26%
Readers by discipline Count As %
Medicine and Dentistry 7 30%
Pharmacology, Toxicology and Pharmaceutical Science 6 26%
Agricultural and Biological Sciences 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Economics, Econometrics and Finance 1 4%
Other 1 4%
Unknown 6 26%